| Novartis Pharma Schweiz AG - Certican 0.75 mg, Tabletten | | 56238 | | 02 | | Certican 0.75 mg | | Tabletten | | L04AA18 | | Everolimus | | 21.04.2005 | | |
| | Composition | | everolimusum 0.75 mg, lactosum monohydricum 6.68 mg, hypromellosum, magnesii stearas, crospovidonum, lactosum 111.56 mg, E 321, pro compresso. | | Packungsbestandteile | | Tablets | | | | | Active Agent | Dose |
|---|
| Everolimus | 0.75 mg |
| | BAG: Active Agent | Dose |
|---|
| Everolimus | 0.75 mg |
| | | | Inactive agents | Dose |
|---|
| Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactosum | 111.56 mg | | Lactose Monohydrate | 6.68 mg | | Magnesii Stearas | | | Pro Compresso | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 60 Tablet(s) | 436.91 | 491.60 | B | SL | No |
|
|
